Wockhardt Unveils Zaynich, Eyes Global Impact and $7 Billion Windfall

Unknown Apr 02, 2026 900 Views

Wockhardt is setting its sights on a $7 billion market opportunity in the US and Europe with its new antibiotic, Zaynich, which targets serious gram-negative infections. The company expects to launch Zaynich in India later this year and is preparing regulatory filings for major global markets....